This brand name is authorized in Austria, Australia, Brazil, Estonia, France, Hong Kong, Mexico, United Kingdom
The drug INDOCID contains one active pharmaceutical ingredient (API):
|
1
Indometacin
UNII 0IMX38M2GG - INDOMETHACIN SODIUM
|
|
Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| INDOCID Capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| INDOCID Suppositories | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01EB03 | Indometacin | C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations |
| M01AB01 | Indometacin | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances |
| M02AA23 | Indometacin | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use |
| S01BC01 | Indometacin | S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2454E, 2757D, 5126T, 5128X, 5377B |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 505609501111317, 505609502118315 |
| Country: EE | Ravimiamet | Identifier(s): 1205626, 1274532, 1870084 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 66664685, 68142440 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 18784 |
| Country: HK | Department of Health Drug Office | Identifier(s): 01934 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 61533, 64785 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
